510(k) K132822
K132822 is an FDA 510(k) premarket notification submitted by Geneohm Sciences Canada, Inc. (Bd Diagnostics) for the device "BD MAX STAPHSR ASSAY, INSTRUMENT". The FDA issued a decision of Substantially Equivalent on Nov 26, 2013. The device falls under product code NQX (System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen), a Class II device regulated under 21 CFR 866.1640. Geneohm Sciences Canada, Inc. (Bd Diagnostics) has 3 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Nov 26, 2013
- Date Received
- Sep 9, 2013
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
- Device Class
- Class II
- Regulation Number
- 866.1640
- Review Panel
- MI
- Submission Type
- 510(k)
A nucleic acid amplification assay system (including probes, other reagents, and instrumentation) is an aid in the identification of MRSA colonization status for the prevention and control of MRSA infections in healthcare settings.
Need the full FDA record for Geneohm Sciences Canada, Inc. (Bd Diagnostics)? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.